The use of placebos in controlled clinical trials must be justified by a positive risk-benefit analysis, and the subjects must be fully informed of the risks involved in the assignment to the placebo group. ... Understanding which subjects are 'placeboresponders', in that they experience a high degree of placebo effect.
